BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 25252690)

  • 1. Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferation.
    Heinig K; Gätjen M; Grau M; Stache V; Anagnostopoulos I; Gerlach K; Niesner RA; Cseresnyes Z; Hauser AE; Lenz P; Hehlgans T; Brink R; Westermann J; Dörken B; Lipp M; Lenz G; Rehm A; Höpken UE
    Cancer Discov; 2014 Dec; 4(12):1448-65. PubMed ID: 25252690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
    Purroy N; Carabia J; Abrisqueta P; Egia L; Aguiló M; Carpio C; Palacio C; Crespo M; Bosch F
    Oncotarget; 2017 Jan; 8(1):742-756. PubMed ID: 27888629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
    Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
    Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion.
    Yu P; Wang Y; Chin RK; Martinez-Pomares L; Gordon S; Kosco-Vibois MH; Cyster J; Fu YX
    J Immunol; 2002 May; 168(10):5117-23. PubMed ID: 11994465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR5-mediated shaping of the lymphoid follicle in chronic lymphocytic leukemia.
    López-Guerra M; Xargay-Torrent S; Colomer D
    Cancer Discov; 2014 Dec; 4(12):1374-6. PubMed ID: 25477106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration.
    Hoellenriegel J; Coffey GP; Sinha U; Pandey A; Sivina M; Ferrajoli A; Ravandi F; Wierda WG; O'Brien S; Keating MJ; Burger JA
    Leukemia; 2012 Jul; 26(7):1576-83. PubMed ID: 22362000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia.
    Feng G; Wang X
    Leuk Lymphoma; 2014 Dec; 55(12):2699-705. PubMed ID: 24547708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.
    Bürkle A; Niedermeier M; Schmitt-Gräff A; Wierda WG; Keating MJ; Burger JA
    Blood; 2007 Nov; 110(9):3316-25. PubMed ID: 17652619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.
    Baudot AD; Jeandel PY; Mouska X; Maurer U; Tartare-Deckert S; Raynaud SD; Cassuto JP; Ticchioni M; Deckert M
    Oncogene; 2009 Sep; 28(37):3261-73. PubMed ID: 19581935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AID-expressing germinal center B cells cluster normally within lymph node follicles in the absence of FDC-M1+ CD35+ follicular dendritic cells but dissipate prematurely.
    Boulianne B; Le MX; Ward LA; Meng L; Haddad D; Li C; Martin A; Gommerman JL
    J Immunol; 2013 Nov; 191(9):4521-30. PubMed ID: 24068672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells.
    Efremov DG; Gobessi S; Longo PG
    Autoimmun Rev; 2007 Dec; 7(2):102-8. PubMed ID: 18035318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premalignant cell dynamics in indolent B-cell malignancies.
    Milpied P; Nadel B; Roulland S
    Curr Opin Hematol; 2015 Jul; 22(4):388-96. PubMed ID: 26049761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion of ZAP-70+ chronic lymphocytic leukemia cells to stromal cells is enhanced by cytokines and blocked by inhibitors of the PI3-kinase pathway.
    Lafarge ST; Johnston JB; Gibson SB; Marshall AJ
    Leuk Res; 2014 Jan; 38(1):109-15. PubMed ID: 23981382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines.
    Weih DS; Yilmaz ZB; Weih F
    J Immunol; 2001 Aug; 167(4):1909-19. PubMed ID: 11489970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406.
    Borge M; Remes Lenicov F; Nannini PR; de los Ríos Alicandú MM; Podaza E; Ceballos A; Fernández Grecco H; Cabrejo M; Bezares RF; Morande PE; Oppezzo P; Giordano M; Gamberale R
    J Immunol; 2014 Sep; 193(6):3165-74. PubMed ID: 25127862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course.
    Dezorella N; Katz BZ; Shapiro M; Polliack A; Perry C; Herishanu Y
    Haematologica; 2016 Dec; 101(12):1553-1562. PubMed ID: 27443285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental stage-dependent collaboration between the TNF receptor-associated factor 6 and lymphotoxin pathways for B cell follicle organization in secondary lymphoid organs.
    Qin J; Konno H; Ohshima D; Yanai H; Motegi H; Shimo Y; Hirota F; Matsumoto M; Takaki S; Inoue J; Akiyama T
    J Immunol; 2007 Nov; 179(10):6799-807. PubMed ID: 17982070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia.
    Boelens J; Lust S; Van Bockstaele F; Van Gele M; Janssens A; Derycke L; Vanhoecke B; Philippé J; Bracke M; Offner F
    Leuk Res; 2009 Oct; 33(10):1335-43. PubMed ID: 19297020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal B-cell antigen receptor signaling activity in vivo elicits germinal center counterselection mechanisms.
    Königsberger S; Weis V; Prodöhl J; Stehling M; Hobeika E; Reth M; Kiefer F
    Eur J Immunol; 2015 Feb; 45(2):603-11. PubMed ID: 25382621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia.
    Paiva C; Rowland TA; Sreekantham B; Godbersen C; Best SR; Kaur P; Loriaux MM; Spurgeon SEF; Danilova OV; Danilov AV
    Haematologica; 2017 Nov; 102(11):1890-1900. PubMed ID: 28838991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.